Neuroprotection against ischemic brain injury conferred by a novel nitrate ester

Bioorg Med Chem Lett. 2002 Oct 21;12(20):2863-6. doi: 10.1016/s0960-894x(02)00631-5.

Abstract

Nitrates exhibit a selectivity of action in different tissue types not fully recognized: in particular, the neuromodulatory and cardiovascular properties can be dissociated. A novel nitrate showed relatively weak systemic effects, but in the middle cerebral artery occlusion rat model of focal ischemia, reduced the cerebral infarct by 60-70% when administered 4 h after the onset of ischemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Brain / pathology
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / pathology
  • Cyclic GMP / physiology
  • Dose-Response Relationship, Drug
  • Guanylate Cyclase / metabolism
  • In Vitro Techniques
  • Infarction, Middle Cerebral Artery / drug therapy
  • Infarction, Middle Cerebral Artery / pathology
  • Muscle Relaxation
  • Muscle, Smooth, Vascular / drug effects
  • Neuroprotective Agents / chemical synthesis*
  • Neuroprotective Agents / pharmacology*
  • Nitrates / chemical synthesis*
  • Nitrates / pharmacology*
  • Nitroglycerin / pharmacology
  • Propane / analogs & derivatives*
  • Propane / pharmacology
  • Rats
  • Vasodilator Agents / pharmacology

Substances

  • GT 715
  • Neuroprotective Agents
  • Nitrates
  • Vasodilator Agents
  • Guanylate Cyclase
  • Nitroglycerin
  • Cyclic GMP
  • Propane